LifeMD, Inc.: Form 10-K for the period ended Dec 31, 2015
Filed with the SEC on Mar 30, 2016 and accepted by EDGAR at Mar 30, 2016, 09:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2015-01-01 to 2015-12-31 | $1.2m | us-gaap:Revenues |
| Cost of revenue | 12 months2015-01-01 to 2015-12-31 | $247.8k | us-gaap:CostOfRevenue |
| Gross profit | 12 months2015-01-01 to 2015-12-31 | $971.1k | us-gaap:GrossProfit |
| Research and development | 12 months2015-01-01 to 2015-12-31 | $23.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2015-01-01 to 2015-12-31 | −$262.2k | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2015-01-01 to 2015-12-31 | $37.5k | us-gaap:InterestExpense |
| Net income | 12 months2015-01-01 to 2015-12-31 | −$62.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2015-01-01 to 2015-12-31 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2015-01-01 to 2015-12-31 | −$295.1k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2015-01-01 to 2015-12-31 | $10.8k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2015-12-31 | $233.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-12-31 | $448.5k | us-gaap:AssetsCurrent |
| Total assets | At period end2015-12-31 | $448.5k | us-gaap:Assets |
| Current liabilities | At period end2015-12-31 | $267.5k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-12-31 | $267.5k | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-12-31 | $100.1k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-16-011978. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.